Innova Captab Limited (INNOVACAP.NS)
INR 875.7
(5.21%)
INR 875.7
(5.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.89 Billion INR | -29.31% |
| 2022 | 6.93 Billion INR | 88.93% |
| 2021 | 3.66 Billion INR | 63.2% |
| 2020 | 2.24 Billion INR | 131359.06% |
| 2019 | 1.71 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -8.3 Billion INR | -269.57% |
| 2023 Q2 | 7.84 Billion INR | 8.92% |
| 2023 FY | 4.89 Billion INR | -29.31% |
| 2023 Q4 | 4.89 Billion INR | 226.11% |
| 2023 Q3 | -3.88 Billion INR | -149.5% |
| 2023 Q1 | 7.2 Billion INR | 3.97% |
| 2022 Q4 | 6.93 Billion INR | 0.0% |
| 2022 FY | 6.93 Billion INR | 88.93% |
| 2021 FY | 3.66 Billion INR | 63.2% |
| 2020 FY | 2.24 Billion INR | 131359.06% |
| 2019 FY | 1.71 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 69.891% |
| Hester Biosciences Limited | 3.59 Billion INR | -36.307% |
| Aarti Drugs Limited | 11.5 Billion INR | 57.407% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | 40.613% |
| Albert David Limited | 1.15 Billion INR | -326.037% |
| Alembic Limited | 1.43 Billion INR | -242.146% |
| Alkem Laboratories Limited | 48.6 Billion INR | 89.919% |
| Bafna Pharmaceuticals Limited | 652.27 Million INR | -651.192% |
| Bajaj HealthCare Limited | 4.86 Billion INR | -0.662% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -1596.637% |
| Brooks Laboratories Limited | 248.6 Million INR | -1870.978% |
| Eris Lifesciences Limited | 38.26 Billion INR | 87.196% |
| FDC Limited | 3.7 Billion INR | -32.1% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | 5.424% |
| Gufic Biosciences Limited | 5.59 Billion INR | 12.499% |
| Hikal Limited | 12.99 Billion INR | 62.294% |
| Ind-Swift Limited | 13.45 Billion INR | 63.578% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 22.579% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -1551.122% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 92.003% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -355.995% |
| Lupin Limited | 96.23 Billion INR | 94.909% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -147.93% |
| Medico Remedies Limited | 438.24 Million INR | -1018.069% |
| Morepen Laboratories Limited | 4.45 Billion INR | -9.868% |
| Nectar Lifesciences Limited | 11.21 Billion INR | 56.322% |
| Orchid Pharma Limited | 3.84 Billion INR | -27.465% |
| Procter & Gamble Health Limited | 2.56 Billion INR | -91.311% |
| RPG Life Sciences Limited | 1.38 Billion INR | -255.012% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -660.988% |
| Sigachi Industries Limited | 2.53 Billion INR | -93.574% |
| Solara Active Pharma Sciences Limited | 14.09 Billion INR | 65.229% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -140.871% |
| Themis Medicare Limited | 1.88 Billion INR | -159.594% |
| Unichem Laboratories Limited | 8.06 Billion INR | 39.277% |
| Vaishali Pharma Limited | 371.16 Million INR | -1220.14% |
| Wanbury Limited | 3.15 Billion INR | -55.279% |
| Windlas Biotech Limited | 1.76 Billion INR | -177.975% |
| ZIM Laboratories Limited | 2.08 Billion INR | -135.484% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -114.018% |
| Ipca Laboratories Limited | 33.74 Billion INR | 85.479% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 97.331% |
| Venus Remedies Limited | 1.39 Billion INR | -251.8% |
| Sakar Healthcare Limited | 1.26 Billion INR | -287.869% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 96.781% |
| Divi's Laboratories Limited | 18.99 Billion INR | 74.198% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | -33.836% |
| Mankind Pharma Limited | 23.87 Billion INR | 79.477% |
| Sequent Scientific Limited | 8.27 Billion INR | 40.782% |
| Laurus Labs Limited | 42.71 Billion INR | 88.529% |
| Neuland Laboratories Limited | 5.49 Billion INR | 10.888% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 54.241% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 92.475% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 93.175% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -525.124% |
| Wockhardt Limited | 39.87 Billion INR | 87.71% |
| Bal Pharma Limited | 2.51 Billion INR | -95.115% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 95.419% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -132.348% |
| Par Drugs and Chemicals Limited | 159.79 Million INR | -2966.424% |
| Caplin Point Laboratories Limited | 3.5 Billion INR | -39.773% |
| Shilpa Medicare Limited | 12.93 Billion INR | 62.112% |
| Valiant Laboratories Limited | 1.05 Billion INR | -363.011% |
| Ajanta Pharma Limited | 10.71 Billion INR | 54.251% |
| Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | -184.514% |
| Granules India Limited | 22.95 Billion INR | 78.654% |
| Medicamen Biotech Limited | 940.36 Million INR | -421.059% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -320.514% |
| Piramal Enterprises Limited | 560.47 Billion INR | 99.126% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 94.028% |
| NATCO Pharma Limited | 10.53 Billion INR | 53.476% |
| Suven Life Sciences Limited | 148.62 Million INR | -3196.889% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | -64.762% |
| Strides Pharma Science Limited | 37.68 Billion INR | 86.996% |
| Indoco Remedies Limited | 10.34 Billion INR | 52.623% |
| Alpa Laboratories Limited | 307.12 Million INR | -1495.415% |
| Lasa Supergenerics Limited | 541.92 Million INR | -804.16% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | -25.867% |